MARINELLI, ALFREDO
 Distribuzione geografica
Continente #
NA - Nord America 729
EU - Europa 691
AS - Asia 342
AF - Africa 7
SA - Sud America 3
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.775
Nazione #
US - Stati Uniti d'America 719
IT - Italia 411
SG - Singapore 166
CN - Cina 94
NL - Olanda 66
HK - Hong Kong 64
UA - Ucraina 57
RU - Federazione Russa 37
FI - Finlandia 33
IE - Irlanda 21
DE - Germania 18
FR - Francia 18
IN - India 13
SE - Svezia 12
CA - Canada 10
GB - Regno Unito 9
CI - Costa d'Avorio 7
DK - Danimarca 4
BR - Brasile 3
CZ - Repubblica Ceca 2
JP - Giappone 2
VN - Vietnam 2
AT - Austria 1
AU - Australia 1
EU - Europa 1
LB - Libano 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 1.775
Città #
Chandler 133
Singapore 113
Naples 81
Amsterdam 64
Hong Kong 64
Napoli 59
Ashburn 43
Santa Clara 39
Millbury 36
Princeton 31
Jacksonville 30
Beijing 22
Nanjing 22
Boston 17
Nanchang 12
Houston 11
Wilmington 11
Milan 10
Des Moines 8
Rome 8
Norwalk 7
Ottawa 7
Bologna 6
Redwood City 6
Rozzano 6
Shenyang 6
Ann Arbor 5
Hebei 5
Marigliano 5
Pune 5
Columbus 4
Helsinki 4
Menfi 4
Mugnano Di Napoli 4
Mumbai 4
Pagani 4
Salerno 4
Seattle 4
Changsha 3
Dallas 3
Dublin 3
Lawrence 3
Serravalle Scrivia 3
Toronto 3
Villaricca 3
Brno 2
Capriati A Volturno 2
Castellammare Di Stabia 2
Dalmine 2
Fairfield 2
Falls Church 2
Florence 2
Genova 2
Hangzhou 2
Hanoi 2
Jiaxing 2
Kochi 2
Kronberg 2
Kunming 2
Latina 2
Mariano Comense 2
Mariglianella 2
Nola 2
Piove Di Sacco 2
Portici 2
Pregnana Milanese 2
Rapolla 2
Scafati 2
Scilla 2
Strasbourg 2
Suri 2
Tianjin 2
Acerra 1
Afragola 1
Andover 1
Arzano 1
Auckland 1
Augusta 1
Aversa 1
Bari 1
Beirut 1
Benevento 1
Boardman 1
Bozen 1
Bucharest 1
Caivano 1
Capena 1
Capua 1
Cariacica 1
Casalnuovo 1
Castelvetrano 1
Catania 1
Catanzaro 1
Cesano 1
Cesenatico 1
Changchun 1
Changzhou 1
Crispano 1
Duncan 1
Formia 1
Totale 1.007
Nome #
null 223
Manuale di Oncologia Clinica 110
null 67
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial 67
null 58
A comprehensive outlook on inracerebral therapy of malignant gliomas 57
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 55
Accanimento terapeutico 51
High grade glioblastoma is associated with aberrant expression of ZFP57, a protein involved in gene imprinting, and of CPT1A and CPT1C that regulate fatty acid metabolism. 49
Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme? 48
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. 47
A comprehensive outlook on intracerebral therapy of malignant gliomas 45
Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer. Ten year results of the Naples (GUN) Study. 44
Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study. 44
A long-lasting response to sorafenib treatment in an advanced hepatocellular carcinoma patient. 43
Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer. 42
Hypothalamic-pituitary-ovarian axis in women with operable breast cancer treated with adjuvant CMF and tamoxifen. 42
Core curriculum. Oncologia clinica 41
Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study. 40
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. 39
Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases. 39
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study). 39
Tumori cerebrali 39
Prognostic significance of multifocality in primary breast cancer. 37
Core curriculum. Oncologia clinica 37
Preliminary analysis of chemotheraphy-induced cardiotoxicity in breast cancer patients trated with Amifostine. 34
Phase II Study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer 34
Relazione medico-paziente e consenso informato 33
Medico e paziente: dalla relazione al consenso 33
Chemotherapy-induced cardiotoxicity: An animal model. 33
DNA methylation-based classification of sinonasal tumors 30
Rapporto medico paziente e consenso informato 30
L'uso dei difosfonati nella terapia delle fratture patologiche della mandibola ad etiologia neoplastica. 30
Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis 29
Chemotherapy-induced cardiotoxicity: An animal model. 29
[Pathological fracture of the mandible: a report of a clinical case treated with clodronate]. 28
High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients 26
Ten-year adjuvant treatment with somatostatin analogs in a patient with atypical carcinoid of the lung. 25
A Root in Synapsis and the Other One in the Gut Microbiome-Brain Axis: Are the Two Poles of Ketogenic Diet Enough to Challenge Glioblastoma? 11
Biweekly fotemustine schedule for recurrent glioblastoma in the elderly: activity and toxicity assessment of a multicenter study 11
Cancer Immunotherapy Using Chimeric Antigen Receptor Expressing T-Cells: Present and Future Needs of Clinical Cancer Centers 8
Cognitive computing tools for identification and classification of brain tumors starting from Magnetic Resonance Imaging: preliminary results 5
Totale 1.832
Categoria #
all - tutte 7.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.547


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202072 0 0 0 0 0 0 0 5 1 19 24 23
2020/2021166 6 10 17 18 16 27 16 6 28 6 14 2
2021/2022234 7 2 2 1 5 5 2 9 23 30 72 76
2022/2023344 34 24 18 26 36 32 10 34 46 65 18 1
2023/2024235 12 37 59 9 18 24 4 21 0 2 27 22
2024/2025391 57 78 2 5 30 52 112 55 0 0 0 0
Totale 1.832